iSOFT wins a A$3.1m Contract with Germany's Damp Holding

iSOFTAustralia's largest listed health information technology company, announced that iSOFT has won a two-year A$3.1 million (€1.65 million) contract with German private healthcare group Damp Holding AG for an integrated radiology information system (RIS) and picture archiving and communications system (PACS).

The enterprise wide system will connect the radiology departments at Damp Holding's six acute care hospitals across Germany and an operating centre in Denmark. The investment includes iSOFT's RadCentre Enterprise. iSOFT is also providing support and maintenance.

Peter Herrmann, managing director of iSOFT Central Europe, said: "There is a marked trend in Europe for hospitals to cooperate to become 'fit for the future' as they face greater competition."

iSOFT's RadCentre Enterprise solution will end the difficulties and delays experienced by the hospitals in retrieving images and reports, and will help make more efficient use of staff time and resources. With instant access to detailed diagnostic reports, doctors can make decisions quickly to improve the quality of healthcare.

Dr Andreas Göpfert, divisional manager of medical services and quality at Damp Holdings, said: "RadCentre Enterprise is a future-proof solution that provides a platform for expansion and integrated services that will underpin our continued success.

"With RadCentre we will have a common platform across all radiology departments to increase efficiency and reduce patient waiting times. The flexibility and scalability of the application allows us to implement our cooperation strategy and the promise of film-free radiology processes with non-location specific reports was an important factor in our choice."

Related news articles:

About IBA Health Group
IBA Health Group Limited (ASX-IBA) is the largest health information technology company listed on the Australian Securities Exchange.

IBA builds software applications for healthcare. We work with healthcare professionals to design and build solutions that answer all of the difficult questions posed by today's care delivery challenges. Our solutions act as a catalyst for change, supporting the free exchange of critical information across diverse care settings and participant organisations. We are the leader in the provision of advanced application solutions in modern healthcare economies around the world.

Today, over 13,000 provider organisations in 35 countries across five continents use IBA's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of our market and anticipation of evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,000 specialists around the globe, including over 1,700 technology and development professionals.

A global network of IBA subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result we offer our customers comprehensive knowledge of local market requirements, in terms of culture, language, working practice, healthcare regulation and organisational structure.

For more information on IBA Health, please visit the company's website at www.ibahealth.com.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...